{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T21:03:47Z","timestamp":1794258227194,"version":"4.9.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T00:00:00Z","timestamp":1607644800000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Thymic epithelial tumors (TETs) are the most common primary tumors in the anterior mediastinum, which have considerable histologic heterogeneity. This study aimed to develop and validate a nomogram based on computed tomography (CT) and texture analysis (TA) for preoperatively predicting the pathological classifications for TET patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Totally TET 172 patients confirmed by postoperative pathology between January 2011 to April 2019 were retrospectively analyzed and randomly divided into training (<jats:italic>n<\/jats:italic>\u2009=\u2009120) and validation (<jats:italic>n<\/jats:italic>\u2009=\u200952) cohorts. Preoperative clinical factors, CT signs and texture features of each patient were analyzed, and prediction models were developed using the least absolute shrinkage and selection operator (LASSO) regression. The performance of the models was evaluated and compared by the area under receiver-operator characteristic (ROC) curve (AUC) and the DeLong test. The clinical application value of the models was determined via the decision curve analysis (DCA). Then, a nomogram was developed based on the model with the best predictive efficiency and clinical utility and validated using the calibration plots.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Totally 87 patients with low-risk TET (LTET) (types A, AB, B1) and 85 patients with high-risk TET (HTET) (types B2, B3, C) were enrolled in this study. We separately constructed 4 prediction models for differentiating LTET from HTET using clinical, CT, texture features, and their combination. These 4 prediction models achieved AUCs of 0.66, 0.79, 0.82, 0.88 in the training cohort and 0.64, 0.82, 0.86, 0.94 in the validation cohort, respectively. The DeLong test and DCA showed that the Combined model, consisting of 2 CT signs and 2 texture parameters, held the highest predictive efficiency and clinical utility (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). A prediction nomogram was subsequently developed using the 4 independently risk factors from the Combined model. The calibration curves indicated a good consistency between the actual observations and nomogram predictions for differentiating TET classifications.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>A prediction nomogram incorporating both the CT and texture parameters was constructed and validated in our study, which can be conveniently used for the preoperative individualized prediction of the simplified histologic subtypes in TET patients.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s40644-020-00364-5","type":"journal-article","created":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T12:18:49Z","timestamp":1607689129000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Development and validation of a CT-texture analysis nomogram for preoperatively differentiating thymic epithelial tumor histologic subtypes"],"prefix":"10.1186","volume":"20","author":[{"given":"Caiyue","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,11]]},"reference":[{"key":"364_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/RTI.0b013e31828609a0","volume":"28","author":"EM Marom","year":"2013","unstructured":"Marom EM. Advances in Thymoma imaging. J Thorac Imaging. 2013;28:69\u201383.","journal-title":"J Thorac Imaging"},{"key":"364_CR2","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.athoracsur.2003.07.042","volume":"77","author":"K Kondo","year":"2004","unstructured":"Kondo K, Yoshizawa K, Tsuyuguchi M, et al. WHO histologic classification is a prognostic indicator in thymoma. Ann Thorac Surg. 2004;77:1183\u20138.","journal-title":"Ann Thorac Surg"},{"key":"364_CR3","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.athoracsur.2009.11.057","volume":"89","author":"Y Hosaka","year":"2010","unstructured":"Hosaka Y, Tsuchida M, Toyabe S, Umezu H, Eimoto T, Hayashi JI. Masaoka stage and histologic grade predict prognosis in patients with Thymic carcinoma. Ann Thorac Surg. 2010;89:912\u20137.","journal-title":"Ann Thorac Surg"},{"key":"364_CR4","unstructured":"Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. WHO classification of Tumours of the lung, pleura, Thymus and heart. Fourth ed. Lyon:\u00a0International Agency for Research on Cancer; 2015."},{"key":"364_CR5","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1002\/cncr.10226","volume":"94","author":"M Okumura","year":"2002","unstructured":"Okumura M, Ohta M, Tateyama H, et al. The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer. 2002;94:624\u201332.","journal-title":"Cancer"},{"key":"364_CR6","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s00259-009-1082-4","volume":"36","author":"A Inoue","year":"2009","unstructured":"Inoue A, Tomiyama N, Tatsumi M, et al. (18) F-FDG PET for the evaluation of thymic epithelial tumors: correlation with the World Health Organization classification in addition to dual-time-point imaging. Eur J Nucl Med Mol Imaging. 2009;36:1219\u201325.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"364_CR7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.lungcan.2014.05.010","volume":"85","author":"R Lattanzio","year":"2014","unstructured":"Lattanzio R, La Sorda R, Facciolo F, et al. Thymic epithelial tumors express vascular endothelial growth factors and their receptors as potential targets of antiangiogenic therapy: a tissue micro array-based multicenter study. Lung Cancer. 2014;85:191\u20136.","journal-title":"Lung Cancer"},{"key":"364_CR8","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/cncr.10665","volume":"95","author":"G Chen","year":"2002","unstructured":"Chen G, Marx A, Chen WH, et al. New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China. Cancer. 2002;95:420\u20139.","journal-title":"Cancer"},{"key":"364_CR9","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2214\/ajr.183.2.1830283","volume":"183","author":"YJ Jeong","year":"2004","unstructured":"Jeong YJ, Lee KS, Kim J, Shim YM, Han JH, Kwon OJ. Does CT of thymic epithelial tumors enable us to differentiate histologic subtypes and predict prognosis? Am J Roentgenol. 2004;183:283\u20139.","journal-title":"Am J Roentgenol"},{"key":"364_CR10","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.athoracsur.2014.09.050","volume":"99","author":"JW Moon","year":"2015","unstructured":"Moon JW, Lee KS, Shin MH, et al. Thymic epithelial tumors: prognostic determinants among clinical, histopathologic, and computed tomography findings. Ann Thorac Surg. 2015;99:462\u201370.","journal-title":"Ann Thorac Surg"},{"key":"364_CR11","doi-asserted-by":"publisher","first-page":"4030","DOI":"10.1007\/s00330-017-4795-y","volume":"27","author":"J Choe","year":"2017","unstructured":"Choe J, Lee SM, Lim S, et al. Doubling time of thymic epithelial tumours on CT: correlation with histological subtype. Eur Radiol. 2017;27:4030\u20136.","journal-title":"Eur Radiol"},{"key":"364_CR12","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3389\/fonc.2019.01041","volume":"9","author":"X Han","year":"2019","unstructured":"Han X, Gao W, Chen Y, et al. Relationship between computed tomography imaging features and clinical characteristics, Masaoka-Koga stages, and World Health Organization histological classifications of Thymoma. Front Oncol. 2019;9:1041.","journal-title":"Front Oncol"},{"key":"364_CR13","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s13244-012-0196-6","volume":"3","author":"F Davnall","year":"2012","unstructured":"Davnall F, Yip CS, Ljungqvist G, et al. Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? Insights Imaging. 2012;3:573\u201389.","journal-title":"Insights Imaging"},{"key":"364_CR14","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1102\/1470-7330.2013.0015","volume":"13","author":"B Ganeshan","year":"2013","unstructured":"Ganeshan B, Miles KA. Quantifying tumour heterogeneity with CT. Cancer Imaging. 2013;13:140\u20139.","journal-title":"Cancer Imaging"},{"key":"364_CR15","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1148\/rg.2017170056","volume":"37","author":"MG Lubner","year":"2017","unstructured":"Lubner MG, Smith AD, Sandrasegaran K, Sahani DV, Pickhardt PJ. CT texture analysis: definitions, applications, biologic correlates, and challenges. Radiographics. 2017;37:1483\u2013503.","journal-title":"Radiographics"},{"key":"364_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/RCT.0000000000000320","volume":"40","author":"A Fujita","year":"2016","unstructured":"Fujita A, Buch K, Li B, Kawashima Y, Qureshi MM, Sakai O. Difference between HPV-positive and HPV-negative non-Oropharyngeal head and neck Cancer: texture analysis features on CT. J Comput Assist Tomogr. 2016;40:43\u20137.","journal-title":"J Comput Assist Tomogr"},{"key":"364_CR17","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1002\/jmri.25460","volume":"45","author":"LH Liu","year":"2017","unstructured":"Liu LH, Liu YH, Xu L, et al. Application of texture analysis based on apparent diffusion coefficient maps in discriminating different stages of rectal cancer. J Magn Reson Imaging. 2017;45:1798\u2013808.","journal-title":"J Magn Reson Imaging"},{"key":"364_CR18","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ejrad.2017.04.017","volume":"92","author":"K Yasaka","year":"2017","unstructured":"Yasaka K, Akai H, Nojima M, et al. Quantitative computed tomography texture analysis for estimating histological subtypes of thymic epithelial tumors. Eur J Radiol. 2017;92:84\u201392.","journal-title":"Eur J Radiol"},{"key":"364_CR19","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s11547-017-0845-4","volume":"123","author":"A Iannarelli","year":"2018","unstructured":"Iannarelli A, Sacconi B, Tomei F, et al. Analysis of CT features and quantitative texture analysis in patients with thymic tumors: correlation with grading and staging. Radiol Med. 2018;123:345\u201350.","journal-title":"Radiol Med"},{"key":"364_CR20","doi-asserted-by":"publisher","unstructured":"Kirienko M, Ninatti G, Cozzi L, et al. Computed tomography (CT)-derived radiomic features differentiate prevascular mediastinum masses as thymic neoplasms versus lymphomas. Radiol Med. https:\/\/doi.org\/10.1007\/s11547-020-01188-w.","DOI":"10.1007\/s11547-020-01188-w"},{"key":"364_CR21","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.1158\/0008-5472.CAN-18-0125","volume":"78","author":"C Nioche","year":"2018","unstructured":"Nioche C, Orlhac F, Boughdad S, et al. LIFEx: a freeware for Radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity. Cancer Res. 2018;78:4786\u20139.","journal-title":"Cancer Res"},{"key":"364_CR22","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2967\/jnumed.116.181859","volume":"58","author":"F Orlhac","year":"2017","unstructured":"Orlhac F, Nioche C, Soussan M, Buvat I. Understanding changes in tumor textural indices in PET: a comparison between visual assessment and index values in simulated and patient data. J Nuclear Med. 2017;58:387\u201392.","journal-title":"J Nuclear Med."},{"key":"364_CR23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","volume":"58","author":"R Tibshirani","year":"1996","unstructured":"Tibshirani R. Regression shrinkage and selection via the Lasso. J Royal Stat Soc Series B-Methodological. 1996;58:267\u201388.","journal-title":"J Royal Stat Soc Series B-Methodological"},{"key":"364_CR24","doi-asserted-by":"publisher","first-page":"5512","DOI":"10.1002\/sim.3148","volume":"26","author":"W Sauerbrei","year":"2007","unstructured":"Sauerbrei W, Royston P, Binder H. Selection of important variables and determination of functional form for continuous predictors in multivariable model building. Stat Med. 2007;26:5512\u201328.","journal-title":"Stat Med"},{"key":"364_CR25","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1200\/JCO.2004.10.113","volume":"22","author":"P Strobel","year":"2004","unstructured":"Strobel P, Bauer A, Puppe B, et al. Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis. J Clin Oncol. 2004;22:1501\u20139.","journal-title":"J Clin Oncol"},{"key":"364_CR26","doi-asserted-by":"publisher","first-page":"6794","DOI":"10.21037\/jtd.2018.11.81","volume":"10","author":"XL Feng","year":"2018","unstructured":"Feng XL, Lei XB, Dong WT, et al. Incidence and clinical variable inter-relationships of thymic epithelial tumors in Northwest China. J Thorac Dis. 2018;10:6794\u2013802.","journal-title":"J Thorac Dis"},{"key":"364_CR27","doi-asserted-by":"publisher","first-page":"881","DOI":"10.2214\/ajr.179.4.1790881","volume":"179","author":"N Tomiyama","year":"2002","unstructured":"Tomiyama N, Johkoh T, Mihara N, et al. Using the World Health Organization classification of thymic epithelial neoplasms to describe CT findings. Am J Roentgenol. 2002;179:881\u20136.","journal-title":"Am J Roentgenol."},{"key":"364_CR28","doi-asserted-by":"publisher","first-page":"6984","DOI":"10.1038\/srep06984","volume":"4","author":"YC Hu","year":"2014","unstructured":"Hu YC, Wu L, Yan LF, et al. Predicting subtypes of thymic epithelial tumors using CT: new perspective based on a comprehensive analysis of 216 patients. Sci Rep. 2014;4:6984.","journal-title":"Sci Rep"},{"key":"364_CR29","first-page":"3616852","volume":"2019","author":"X Wang","year":"2019","unstructured":"Wang X, Sun W, Liang H, Mao X, Lu Z. Radiomics signatures of computed tomography imaging for predicting risk categorization and clinical stage of Thymomas. Biomed Res Int. 2019;2019:3616852.","journal-title":"Biomed Res Int"},{"key":"364_CR30","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/s00234-016-1758-y","volume":"58","author":"R Raja","year":"2016","unstructured":"Raja R, Sinha N, Saini J, Mahadevan A, Rao KN, Swaminathan A. Assessment of tissue heterogeneity using diffusion tensor and diffusion kurtosis imaging for grading gliomas. Neuroradiology. 2016;58:1217\u201331.","journal-title":"Neuroradiology"},{"key":"364_CR31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40644-019-0243-3","volume":"19","author":"S Chen","year":"2019","unstructured":"Chen S, Harmon S, Perk T, et al. Using neighborhood gray tone difference matrix texture features on dual time point PET\/CT images to differentiate malignant from benign FDG-avid solitary pulmonary nodules. Cancer Imaging. 2019;19:56.","journal-title":"Cancer Imaging"},{"key":"364_CR32","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s11548-019-02093-y","volume":"15","author":"JR Ferreira-Junior","year":"2020","unstructured":"Ferreira-Junior JR, Koenigkam-Santos M, Magalhaes Tenorio AP, et al. CT-based radiomics for prediction of histologic subtype and metastatic disease in primary malignant lung neoplasms. Int J Comput Assist Radiol Surg. 2020;15:163\u201372.","journal-title":"Int J Comput Assist Radiol Surg"},{"key":"364_CR33","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1007\/s00330-011-2319-8","volume":"22","author":"B Ganeshan","year":"2012","unstructured":"Ganeshan B, Panayiotou E, Burnand K, Dizdarevic S, Miles K. Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival. Eur Radiol. 2012;22:796\u2013802.","journal-title":"Eur Radiol"},{"key":"364_CR34","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","volume":"15","author":"I Dagogo-Jack","year":"2018","unstructured":"Dagogo-Jack I, Shaw AT. Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol. 2018;15:81\u201394.","journal-title":"Nat Rev Clin Oncol"},{"key":"364_CR35","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1309\/CYJH-9RXM-P2PK-120J","volume":"114","author":"CA Moran","year":"2000","unstructured":"Moran CA, Suster S. On the histologic heterogeneity of thymic epithelial neoplasms - impact of sampling in subtyping and classification of thymomas. Am J Clin Pathol. 2000;114:760\u20136.","journal-title":"Am J Clin Pathol"},{"key":"364_CR36","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.6004\/jnccn.2010.0097","volume":"8","author":"RT Cheney","year":"2010","unstructured":"Cheney RT. The biologic Spectrum of Thymic epithelial neoplasms: current status and future prospects. J Natl Compr Cancer Netw. 2010;8:1322\u20138.","journal-title":"J Natl Compr Cancer Netw"},{"key":"364_CR37","doi-asserted-by":"publisher","first-page":"890","DOI":"10.18632\/oncotarget.1015","volume":"4","author":"J Wheler","year":"2013","unstructured":"Wheler J, Hong D, Swisher SG, et al. Thymoma patients treated in a phase I clinic at MD Anderson Cancer Center: responses to mTOR inhibitors and molecular analyses. Oncotarget. 2013;4:890\u20138.","journal-title":"Oncotarget"},{"key":"364_CR38","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1148\/radiol.2019190829","volume":"293","author":"HJ Park","year":"2019","unstructured":"Park HJ, Son JH, Kim TB, et al. Relationship between lower dose and injection speed of iodinated contrast material for CT and acute hypersensitivity reactions: an observational study. Radiology. 2019;293:565\u201372.","journal-title":"Radiology"},{"key":"364_CR39","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1097\/JTO.0000000000000290","volume":"9","author":"FC Detterbeck","year":"2014","unstructured":"Detterbeck FC, Stratton K, Giroux D, et al. The IASLC\/ITMIG Thymic epithelial tumors staging project: proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol. 2014;9:S65\u201372.","journal-title":"J Thorac Oncol"},{"key":"364_CR40","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","volume":"48","author":"A Masaoka","year":"1981","unstructured":"Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up-study of Thymomas with special reference to their clinical stages. Cancer. 1981;48:2485\u201392.","journal-title":"Cancer"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-020-00364-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40644-020-00364-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-020-00364-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,18]],"date-time":"2024-08-18T22:33:08Z","timestamp":1724020388000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerimagingjournal.biomedcentral.com\/articles\/10.1186\/s40644-020-00364-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["364"],"URL":"https:\/\/doi.org\/10.1186\/s40644-020-00364-5","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"26 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Our Institutional Review Boards (Shanghai Proton and Heavy Ion Center and Fudan University Shanghai Cancer Center Medical Ethics Committees) approved this retrospective study and waived the need for informed consent from patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the content and agree to submit for consideration for publication in the journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"86"}}